Edge Therapeutics CEO Brian Leuthner's 2018 pay jumps 72% to $4.4M

Edge Therapeutics reports 2018 executive compensation

By ExecPay News

Published: August 15, 2019

Edge Therapeutics reported fiscal year 2018 executive compensation information on August 15, 2019.
In 2018, five executives at Edge Therapeutics received on average a compensation package of $1.7M, a 16% increase compared to previous year.
Average pay of disclosed executives at Edge Therapeutics
Brian A. Leuthner, Chief Executive Officer, received $4.4M in total, which increased by 72% compared to 2017. 77.06% of Leuthner's compensation, or $3.4M, was in option awards. Leuthner also received $318K in bonus, $530K in salary, $143.8K in stock awards, as well as $7.5K in other compensation.
W. Bradford Middlekauff, General Counsel, received a compensation package of $1.3M, which increased by 73% compared to previous year. 58.63% of the compensation package, or $791.4K, was in option awards.
Herbert J. Faleck, Chief Medical Officer, earned $1.3M in 2018, a 2% increase compared to previous year.
Andrew Saik, Chief Financial Officer, received $1.3M in 2018, which decreases by 23% compared to 2017.
R. Loch Macdonald, Chief Scientific Officer, earned $443K in 2018, a 66% decrease compared to previous year.

Related executives

Brian Leuthner

Edge Therapeutics

Chief Executive Officer

R Macdonald

Edge Therapeutics

Chief Scientific Officer

Herbert Faleck

Edge Therapeutics

Chief Medical Officer

Andrew Saik

Edge Therapeutics

Chief Financial Officer

W Middlekauff

Edge Therapeutics

General Counsel

You may also like

Source: SEC filing on August 15, 2019.